Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Randomized double-blind placebo-controlled crossover trial of inhaled dry powder mannitol (Bronchitol) in children with cystic fibrosis
2012-002699-14Phase 2Completed
- Sponsor
- Pharmaxis
- Start
- Jul 2012
- Modality
- Small Molecules, Inhalation Devices → Device-based Delivery → Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of Bronchitol in cystic fibrosis (CF) (2 arms), sponsored by Pharmaxis. Primary endpoint: Change in percentage of predicted FEV1. Started Jul 2012; status: completed.
02
Drugs
Bronchitol
03
Conditions
cystic fibrosis (CF)
Beyond the preview
Go deeper on 2012-002699-14.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2012-002699-14.